TradingHolo

The whole market. One view. Market data from our own platform. Not investment advice. Prices in listing currency with AED alongside; market cap in USD. Live = streaming now; Delayed 15 min where the exchange requires it; At close = last official close.

News Calendar Economy IPOs ETFs Account

⌂Home ◈Markets ▦Screener 📈Tools ◎Portfolio

Skip to content

DFM General5,713.78−1.79%FTSE ADX9,572.23−1.34%TASI9,695.86−2.32%QE Index8,611.10−0.37%S&P 5007,663.43−1.21%Nasdaq 10028,958.69−2.90%Nifty 5022,600.00−0.39%Sensex73,123.83−0.17%KSE-100163,406.20−0.32%DFM:EMIRATESNBDAED 29.70−4.44%ADX:IHCAED 350.00−0.57%SAU:2222SAR 25.40−0.70%DSMD:QNBKQAR 15.50−1.02%NAS:NVDA$212.21−4.40%NYSE:TSM$412.35−4.52%NSE:RELIANCE₹1,190.00+0.46%KAR:OGDCRs 299.48−0.34%Gold$4,023.84−0.02%Brent$114.37+1.31%BTC$81,676.51+0.45%ETH$2,400.84+0.62%DFM General5,713.78−1.79%FTSE ADX9,572.23−1.34%TASI9,695.86−2.32%QE Index8,611.10−0.37%S&P 5007,663.43−1.21%Nasdaq 10028,958.69−2.90%Nifty 5022,600.00−0.39%Sensex73,123.83−0.17%KSE-100163,406.20−0.32%DFM:EMIRATESNBDAED 29.70−4.44%ADX:IHCAED 350.00−0.57%SAU:2222SAR 25.40−0.70%DSMD:QNBKQAR 15.50−1.02%NAS:NVDA$212.21−4.40%NYSE:TSM$412.35−4.52%NSE:RELIANCE₹1,190.00+0.46%KAR:OGDCRs 299.48−0.34%Gold$4,023.84−0.02%Brent$114.37+1.31%BTC$81,676.51+0.45%ETH$2,400.84+0.62%

Stock markets

🇦🇪UAEDFM · ADX · DFM GeneralOpen 🇸🇦Saudi ArabiaTadawul · TASIClosed 🇶🇦QatarQSE · QE GeneralClosed 🇺🇸United StatesNasdaq · NYSE · S&P 500Closed 🇮🇳IndiaNSE · BSE · Nifty 50Closed 🇵🇰PakistanPSX · KSE-100Open

Other assets

₿CryptoRanked by volume · 24/7 🥇Gold, FX & economyDubai gold, AED crosses, rates ◫ETFsIndex, sector and gold funds

Explore

▦Market mapEvery market as a heatmap 📅Calendar & IPOsEarnings, dividends, listings, releases ⌁Options flow · Ownership · PoliticsUS filings and tapes

⚲Stock screenerAll six markets, one row per company ★Ready-made screensStarting points with a point of view 📁My saved screensSaved rules with alerts on new matches ⇄CompareUp to five, side by side

📈ChartingDrawings, indicators, replay ▶Strategy MakerWrite a rule, test it on history ⇄CompareSide by side 🔔AlertsPrice, earnings, screens, strategies

⌕

Sign in Create account👤

Markets › United States › NAS › ABIO

A

ARCA biopharma, Inc.

NAS:ABIOHealthcare

——At close · Market cap —

🔔 Alert▶ Test a strategy

Overview Chart Financials Valuation Forecasts Dividends Ownership Options Shorts News Profile

ARCA biopharma, Inc. · Profile · TradingHolo

About ARCA biopharma, Inc.

ARCA biopharma, Inc. operates as a clinical-stage biopharmaceutical company dedicated to the creation and commercialization of genetically targeted therapies designed to address various cardiovascular ailments. The company's leading therapeutic programs feature two key candidates: Recombinant Nematode Anticoagulant Protein c2 (rNAPc2), known as AB201, which is currently being evaluated in a Phase IIb clinical trial for its potential in treating COVID-19. Gencaro (bucindolol hydrochloride), a distinctive pharmacogenetically-targeted beta-adrenergic receptor antagonist. This compound has already concluded its Phase IIb trial, demonstrating efficacy for the management of atrial fibrillation in patients afflicted with chronic heart failure. To further its research and development efforts, ARCA biopharma has established strategic collaborations. These include a partnership with LabCorp aimed at developing a genetic test for the GENETIC-AF clinical trial, as well as a research alliance with the Colorado Prevention Center (an academic research organization of the University of Colorado) focused on advancing and commercializing Gencaro. Founded in 2004, the company is based in Westminster, Colorado.

Facts

CEOThomas A. Keuer

Employees3

Listed sinceFri, 8 Aug 1997

HeadquartersWestminster, CO, US

Websiteorukatx.com

ISINUS00211Y5069

SectorHealthcare

IndustryBiotechnology

Beta0.90